181 related articles for article (PubMed ID: 32472423)
1. Practical applications of studies on the TSH receptor and TSH receptor autoantibodies.
Furmaniak J; Sanders J; Sanders P; Miller-Gallacher J; Ryder MM; Rees Smith B
Endocrine; 2020 May; 68(2):261-264. PubMed ID: 32472423
[TBL] [Abstract][Full Text] [Related]
2. A novel third-generation TSH receptor antibody (TRAb) enzyme-linked immunosorbent assay based on a murine monoclonal TSH receptor-binding antibody.
Roggenbuck JJ; Veiczi M; Conrad K; Schierack P; Wunderlich G; Kotzerke J; Roggenbuck D; Zöphel K
Immunol Res; 2018 Dec; 66(6):768-776. PubMed ID: 30684216
[TBL] [Abstract][Full Text] [Related]
3. Blocking type TSH receptor antibodies.
Furmaniak J; Sanders J; Rees Smith B
Auto Immun Highlights; 2013 Apr; 4(1):11-26. PubMed ID: 26000138
[TBL] [Abstract][Full Text] [Related]
4. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.
Sanders J; Miguel RN; Furmaniak J; Smith BR
Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929
[TBL] [Abstract][Full Text] [Related]
5. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
[TBL] [Abstract][Full Text] [Related]
6. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
[TBL] [Abstract][Full Text] [Related]
8. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
McLachlan SM; Aliesky HA; Rapoport B
Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
[No Abstract] [Full Text] [Related]
9. Estimation of serum TSH receptor autoantibody concentration and affinity.
Nakatake N; Sanders J; Richards T; Burne P; Barrett C; Pra CD; Presotto F; Betterle C; Furmaniak J; Smith BR
Thyroid; 2006 Nov; 16(11):1077-84. PubMed ID: 17123333
[TBL] [Abstract][Full Text] [Related]
10. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
11. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
12. TSH-receptor autoantibodies: pathophysiology, assay methods, and clinical applications.
Ehlers M; Allelein S; Schott M
Minerva Endocrinol; 2018 Sep; 43(3):323-332. PubMed ID: 29265783
[TBL] [Abstract][Full Text] [Related]
13. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
14. TSH receptor antibodies.
Smith BR; Sanders J; Furmaniak J
Thyroid; 2007 Oct; 17(10):923-38. PubMed ID: 17900238
[TBL] [Abstract][Full Text] [Related]
15. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.
Sanders J; Bolton J; Sanders P; Jeffreys J; Nakatake N; Richards T; Evans M; Kiddie A; Summerhayes S; Roberts E; Miguel RN; Furmaniak J; Smith BR
Thyroid; 2006 Dec; 16(12):1195-206. PubMed ID: 17199429
[TBL] [Abstract][Full Text] [Related]
16. Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.
Mizutori Y; Chen CR; Latrofa F; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2009 Mar; 94(3):927-35. PubMed ID: 19066298
[TBL] [Abstract][Full Text] [Related]
17. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
[TBL] [Abstract][Full Text] [Related]
18. TSH receptor - autoantibody interactions.
Rees Smith B; Sanders J; Evans M; Tagami T; Furmaniak J
Horm Metab Res; 2009 Jun; 41(6):448-55. PubMed ID: 19530271
[TBL] [Abstract][Full Text] [Related]
19. Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies.
Latrofa F; Chazenbalk GD; Pichurin P; Chen CR; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2004 Sep; 89(9):4734-45. PubMed ID: 15356088
[TBL] [Abstract][Full Text] [Related]
20. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]